Thursday, 30 June 2022


China introduces whole course management system for osteoporosis patients

22 December 2021 | News

Online healthcare services empower drug distribution and enhance accessibility to quality innovative drugs

image credit- prnewswire

image credit- prnewswire

Ping An Healthcare and Technology Company has entered into a strategic partnership with a leading Japanese pharmaceutical company, Chugai Pharma China, to set up an osteoporosis clinic and establish a whole course management system for osteoporosis patients. The partnership strives to increase the accessibility to quality innovative drugs and benefit osteoporosis patients.

The clinic will integrate services for osteoporosis patients including health education, disease prevention, consultation, drug purchase and rehabilitation etc., so as to optimize the online and offline closed-loop management system. It will also generate a life-cycle membership file for each patient based on the family doctor membership and coordinate the online and offline healthcare services for them.

In addition, Ping An Good Doctor will seek to explore further cooperation with Chugai Pharma China in terms of hospital, osteoporosis specialist doctors and professional training.

Approximately one-fifth of the population aged over 50 years suffer from osteoporosis in China, according to statistics, but their awareness rate of the disease is only 7 per cent. In addition, osteoporosis has a high false-negative rate and the treatment is complex as it involves multiple medical departments including orthopedics, endocrinology, rheumatology and immunology etc. It also lacks a professional full-cycle care management platform. Therefore, it is important to enhance the awareness of osteoporosis and raise health consciousness among the public.

 

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account